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Leishmania parasites infect macrophages, cells nor-
mally involved in innate defense against pathogens.
Leishmania amazonensis and Leishmania major
cause severeormilddisease, respectively, consistent
with each parasite’s ability to survive within activated
macrophages. Themechanismsunderlying increased
virulence of L. amazonensis are mostly unknown. We
show that L. amazonensis promotes its own survival
by inducing expression of CD200, an immunoregula-
tory molecule that inhibits macrophage activation.
L. amazonensis does not form typical nonhealing
lesions in CD200/ mice and cannot replicate in
CD200/ macrophages, an effect reversed by exog-
enous administration of soluble CD200-Fc. The less
virulent L. major does not induce CD200 expression
and forms small, self-healing lesions in both wild-
type andCD200/mice.Notably,CD200-Fc injection
transforms the course of L. major infection to one
resembling L. amazonensis, with large, nonhealing
lesions. CD200-dependent iNOS inhibition allows
parasitegrowth inmacrophages, identifyingamecha-
nism for the increased virulence of L. amazonensis.
INTRODUCTION
The parasitic protozoan Leishmania infects millions of people
worldwide. Leishmaniasis is a growing public health threat due
to recent increases in transmission by infected sand flies.
Different species of Leishmania cause awide spectrum of human
disease, from self-healing cutaneous lesions to lethal visceraliz-
ing infections. The parasite factors responsible for the different
forms of clinical disease have not been elucidated. In this study
we investigate this issue by comparing two species that cause
cutaneous lesions, L. amazonensis and L. major (Afonso and
Scott, 1993; Jones et al., 2000, 2002). Infections with
L. amazonensis and L. major cause severe or mild disease,
respectively (Barral et al., 1991; McMahon-Pratt and Alexander,
2004), and these differences in virulence have been proposed to
be associated with the ability of each pathogen to survive withinCell Hactivated macrophages (Barral et al., 1991; Gomes et al., 2003;
McMahon-Pratt and Alexander, 2004; Qi et al., 2004; Scott and
Sher, 1986). However, the molecular mechanisms responsible
for the resistance of L. amazonensis to microbicidal responses
and for its enhanced virulence remain largely unknown.
Immune responses of myeloid cells can be controlled by
a number of inhibitory receptors (Ravetch and Lanier, 2000).
Among the best-characterized immune inhibitory ligand-
receptor pairs is CD200 and its receptor CD200R. CD200 (OX2)
is a cell surface glycoprotein from the immunoglobulin super-
family that is expressed in several cell types, particularly
lymphoid cells, neurons, and endothelium (Barclay et al., 2002).
CD200 has a very short intracellular tail that does not contain
any known signaling motif. By engaging CD200R, a cell surface
receptor that contains three conserved tyrosines in its cytosolic
domain, CD200 generates an inhibitory signal that prevents local
macrophage activation (Foster-Cuevas et al., 2004; Hoek et al.,
2000;Wright et al., 2000). CD200R iswidely expressed inmyeloid
cells, but resting macrophages express low or undetectable
levels of CD200 ligand (Mukhopadhyay et al., 2010). In this study
we show that L. amazonensis, but not L. major, has the ability to
inducemacrophages toexpressCD200, resulting inadampening
of macrophage microbicidal responses and an increase in para-
site intracellular survival and virulence.RESULTS
L. amazonensis-Induced Expression of CD200 in Host
Macrophages Is Required for Intracellular Replication
of the Parasites
Transcriptome analysis of C57BL/6 bone marrow macrophages
(BMMs) infected with L. amazonensis detected an increase in
CD200 mRNA levels (C.H., K.A.K., A.A., and N.W.A., unpublished
data). Real-time PCR analysis confirmed a marked increase in
CD200 mRNA 1 hr after infection of BMM with L. amazonensis
axenic amastigotes (Figure 1A), with a concomitant increase in
CD200 protein levels (Figure 1B). Interestingly, at 6 or 24 hr after
infection, CD200 levels were again reduced, indicating that the
signals responsible for the activation of CD200 expression are
restricted to early stages of interaction of the parasites with the
macrophage. The small but significant increase in CD200 expres-
siondetectedat48hrafter infection (Figure1A)may reflect reinfec-
tion ofmacrophages by parasites released fromneighboring cells.ost & Microbe 9, 463–471, June 16, 2011 ª2011 Elsevier Inc. 463
Figure 1. CD200 Expression Is Required for
L. amazonensis Growth in Macrophages
(A) CD200 transcript levels measured by qPCR in
BMMs infected for 1 hr with L. amazonensis axenic
amastigotes and either processed immediately or
after incubation for 6, 24, or 48 hr. Results corre-
spond to mean ± SD of triplicates. ***p < 0.0001;
**p < 0.0075 (Student’s t test).
(B) Immunoblot of CD200 protein levels in BMMs
infected (I) or not (NI) for 1 hr with axenic amasti-
gotes. Mouse splenocytes (S) were used as
a positive control.
(C) Intracellular L. amazonensis over time in WT
and CD200/ BMMs infected for 1 hr with axenic
amastigotes and either fixed immediately or after
incubation for 24 or 48 hr. Results correspond to
mean ± SD of triplicates. *p < 0.0270; **p < 0.0035
(Student’s t test).
(D) Images of L. amazonensis-infected WT or
CD200/ BMMs, 1 and 48 hr after infection.
Nuclei were stained with DAPI (blue); para-
sitophorous vacuole membranes were stained
with antibodies to the lysosomal glycoprotein
Lamp1 (green); parasites were stained with anti-
Leishmania antibodies (red).
(E) Intracellular L. amazonensis in WT and
CD200/ BMMs infected for 1 hr in the presence
or not of CD200-Fc. Results correspond tomean ±
SD of triplicates. *p < 0.0138, 24 hr; *p < 0.0150,
48 hr (Student’s t test).
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Leishmania Virulence Requires CD200 ExpressionWe found that CD200 expression was required for
L. amazonensis replication inmacrophages. The number of intra-
cellular parasites doubled approximately every 24 hr in wild-type
(WT) BMMs, while no significant growth was observed in BMMs
isolated from CD200/ mice (Figures 1C and 1D). Importantly,
treatment of CD200/ BMMs with a CD200-Fc fusion protein
(Snelgrove et al., 2008) rescued their ability to support the intra-
cellular replication of L. amazonensis, while not affecting parasite
growth in WT BMM (Figure 1E). A control IgG1-Fc fusion protein
lacking the CD200 sequence had no effect on the intracellular
growth of L. amazonensis in BMM (Figure S1).
CD200 Expression Inhibits L. amazonensis-Induced
iNOS and NO Production
Nitric oxide (NO) production by inducible nitric oxide synthase
(iNOS) is a major mechanism used by macrophages to kill intra-464 Cell Host & Microbe 9, 463–471, June 16, 2011 ª2011 Elsevier Inc.cellular Leishmania (Liew et al., 1990;
Qadoumi et al., 2002; Wei et al., 1995)
and to prevent reactivation of latent leish-
maniasis (Stenger et al., 1996). Of partic-
ular relevance for the present studies,
iNOS/NO production by macrophages
also plays a prominent role during early
stages of the innate immune response
against L. major (Diefenbach et al.,
1998). Since CD200 signaling was shown
to suppress iNOS-mediated generation
of NO (Banerjee and Dick, 2004;
Cameron et al., 2005; Copland et al.,
2007), we investigated if this mechanismwas involved in the reduced growth of L. amazonensis after
infection of CD200/ BMMs. Low levels of iNOS expression
were detected by western blot in WT BMM exposed to
L. amazonensis axenic amastigotes, whereas higher levels
were consistently observed in CD200/ BMMs (Figures 2A
and 2B). In agreement with an involvement of iNOS in the restric-
tion of the intracellular growth of L. amazonensis in macrophages
lacking CD200, the specific iNOS inhibitor L-NMMA rescued
parasite replication in CD200/ BMMs. In contrast, the inactive
isomer D-NMMA had no effect (Figures 2C and 2D). A sensitive
fluorometric assay revealed that NO produced by CD200/
BMMs infected with L. amazonensis was elevated when
compared to infected WT BMM (Figure 2E). These NO levels
were markedly lower than what is observed in infected or nonin-
fected BMMs exposed to LPS and IFN-g (Figure S2), consistent
with the observed inhibition in parasite replication instead of
Figure 2. CD200 Promotes L. amazonensis
Intracellular Growth by Downregulating
iNOS
(A) iNOS immunoblot in WT and CD200/ BMMs
infected for 1 hr with L. amazonensis axenic
amastigotes and incubated for the indicated time
points. No iNOS band was detected in lysates of
noninfected BMMs (not shown). Blots were also
probed with anti-actin as a loading control.
(B) Densitometry analysis of the data in (A),
expressed as iNOS/actin ratio.
(C) Intracellular L. amazonensis over time in WT or
CD200/ BMMs pretreated with 500 mM D- or
L-NMMA, infected for 1 hr with axenic amasti-
gotes, and either fixed immediately or after incu-
bation for 24 or 48 hr. Results correspond to
mean ± SD of triplicates. *p < 0.0444; **p < 0.0023
(Student’s t test).
(D) Images of WT andCD200/BMMs pretreated
with D- or L-NMMA, 48 hr after infection. Nuclei
were stained with DAPI (blue); parasitophorous
vacuole membranes were stained with anti-
Lamp1 (green); parasites were stained with anti-
Leishmania (red). Long arrows point to replicating
amastigotes; short arrows point to single, non-
replicating amastigotes.
(E) NO levels in the supernatant of WT and
CD200/ BMMs measured with a fluorometric
assay after 1 hr infection with axenic amastigotes.
Results correspond to mean ± SD of triplicates.
***p = 0.0001; *p = 0.038 (18 hr); p = 0.014 (24 hr)
(Student’s t test).
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observed between CD200+/+ and CD200/ infected BMMs
(results not shown), consistent with previous reports suggesting
that L. amazonensis inhibits iNOS expression in host cells by
a posttranscriptional mechanism (Balestieri et al., 2002;
Wilkins-Rodrı´guez et al., 2010).
CD200 Expression Is Required for Leishmania Virulence
In Vivo
Next, we examined the progression of cutaneous lesions after
inoculation of L. amazonensis into mouse footpads. WT
CD200+/+ mice showed the rapidly growing, nonhealing lesions
that are typical of L. amazonensis infections in C57BL/6 mice.
In sharp contrast,CD200/mice infected with a similar parasite
dose developed smaller lesions that healed by the 12th week
following inoculation (Figure 3A). Quantification of viable
L. amazonensis in infected footpads revealed a 100-fold
expansion in the parasite population between weeks 3 and 5 in
WT mice, while no significant increase was detected during the
same period in CD200/ mice (Figures 3B and S3). Thus,
CD200 expression, which promotes L. amazonensis growth inCell Host & Microbe 9, 463–4macrophages, appears to also lead to
more severe cutaneous lesions in vivo.
The progressive, nonhealing pattern of
L. amazonensis lesion formation in mice
(Jones et al., 2002) resembles the human
disease caused by this Leishmania
species in Central and South America(Barral et al., 1991; McMahon-Pratt and Alexander, 2004).
L. major, an agent of cutaneous leishmaniasis in the Old World,
causes a more benign, self-healing form of human disease,
which can be reproduced in mice of the C57BL/6 background
(Belkaid et al., 2000; Jones et al., 2002). In marked contrast
to L. amazonensis, L. major caused small lesions that healed
within 8–9 weeks in both WT and CD200/ mice (Figure 3C).
Tissue load assays also showed that CD200 expression did
not affect the numbers of viable L. major between 3 and 5 weeks
after infection (Figures 3D and S3). These results suggested
that L. major differs from L. amazonensis in its capacity to
engage CD200 as a strategy for intracellular growth in
macrophages.
Since L. major cannot be grown axenically, we used lesion-
derived amastigotes from both species for our subsequent
in vitro studies of the CD200 effect. We found that L. major infec-
tion, in contrast to L. amazonensis, did not induce CD200 tran-
scription in BMMs (Figures 3E and S4), although infection levels
with both parasite species were comparable (Figure 3F). We also
compared iNOS induction in macrophages infected with either
L. amazonensis or L. major. As observed in infections performed71, June 16, 2011 ª2011 Elsevier Inc. 465
Figure 3. The Reduced Virulence of L. major
Is Associated with Its Inability to Induce
CD200 Expression
(A) Lesion size during infection of WT and
CD200/ mice with L. amazonensis. Results
correspond to mean ± SD (n = 5). *p < 0.021;
**p < 0.0037; ***p < 0.0006 (Student’s t test).
(B) Parasite load in footpads from WT and
CD200/ mice infected with L. amazonensis.
Results correspond to mean ± SD (n = 5).
**p < 0.0025; ***p < 0.0001 (Student’s t test).
(C) Lesion size during infection of WT and
CD200/ mice with L. major. Results correspond
to mean ± SD (n = 5).
(D) Parasite load in footpads from WT and
CD200/ mice infected with L. major. Results
correspond to mean ± SD (n = 5).
(E) CD200 transcript levels determined by qPCR in
BMMs infected for 1 hr with L. amazonensis
(green) or L. major (red) lesion-derived amasti-
gotes. Results correspond to mean ± SD of tripli-
cates. ***p = 0.0001 (Student’s t test).
(F) Numbers of intracellular parasites in the
experiment shown in (E). Results correspond to
mean ± SD of triplicates.
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Leishmania Virulence Requires CD200 Expressionwith axenic amastigotes (Figures 2A and 2B), iNOS levels were
higher in CD200/ BMMs when compared to WT BMMs after
1 hr of infection with L. amazonensis lesion-derived amastigotes
(Figures 4A and 4B). However, the outcome of infection with
L. major lesion-derived amastigotes was markedly different.
iNOS expression was detected after 1 hr of infection in both pop-
ulations of BMMs, independent of CD200 expression (Figures 4A
and 4B). These iNOS expression levels were apparently suffi-
cient to restrict the early intracellular growth of L. major, since
the specific iNOS inhibitor L-NMMA rescued parasite replication
after 48 hr in both WT and CD200/ BMM, whereas the inactive
isomer D-NMMA had no effect (Figure 4C).
The Mild, Self-Healing Course of Infection with L. major
Is Transformed into a Virulent Nonhealing Pattern by
Administration of Soluble CD200-Fc
As observed with axenic amastigotes (Figures 1C and 1E),
L. amazonensis lesion-derived amastigotes grew poorly in466 Cell Host & Microbe 9, 463–471, June 16, 2011 ª2011 Elsevier Inc.CD200/ BMMs, and extracellular addi-
tion of CD200-Fc rescued parasite repli-
cation (Figure 5A). In contrast, L. major
growth was limited in both WT and
CD200/ BMMs (Figure 5B), consistent
with the small, self-healing lesions
observed in mice (Figure 3C). Further-
more, the addition of CD200-Fc to both
WT and CD200/ BMMs promoted
vigorous intracellular growth of L. major
(Figure 5B). In vivo results further sup-
ported the hypothesis that the induction
of CD200 is critical for Leishmania viru-
lence. Administration of CD200-Fc to
L. amazonensis-infected WT mice re-
sulted in slightly larger lesions andincreased tissue parasite load (Figures 5C and 5D). Remarkably,
in vivo inoculation of CD200-Fc converted the mild L. major
phenotype into a much more virulent one, resembling that of
L. amazonensis including nonhealing lesions and a six-log
increase in parasite load (Figures 5C and 5D).
DISCUSSION
Negative regulatory mechanisms within the immune system are
essential to prevent pathology driven by unrestrained inflamma-
tory responses to self and foreign antigens. The widely ex-
pressed and inducible ligand CD200 plays an important role in
this process, by suppressing inflammatory responses on
myeloid cells expressing CD200 receptors (CD200R) (Barclay
et al., 2002). In this study, we demonstrate that the protozoan
parasite L. amazonensis manipulates this potent immune
inhibitory pathway to its advantage by inducing the expres-
sion of CD200. In the absence of CD200, the virulence of
Figure 4. The Reduced Ability of L. major to
Replicate in Macrophages Is Associated
with Induction of iNOS Expression
(A) Immunoblot of iNOS in WT and CD200/
BMMs not infected (NI) or infected for 1 hr with
L. amazonensis or L. major lesion-derived amas-
tigotes. Anti-actin was used as loading control.
(B) Densitometry analysis of the data in (A), ex-
pressed as iNOS/actin ratio.
(C) Intracellular L. major over time in WT or
CD200/ BMMs pretreated with 500 mM D- or
L-NMMA and infected for 1 hr with lesion-derived
amastigotes and either fixed immediately or after
incubation for 24 or 48 hr. Results correspond to
mean ± SD of triplicates. **p = 0.0079 (WT); p =
0.0027 (CD200/) (Student’s t test).
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that does not induce CD200. Concordantly, exogenousCD200 is
capable of increasing the virulence of L. major to levels normally
observed for L. amazonensis.
The detailed mechanism by which CD200 expression
promotes Leishmania virulence in vivo remains to be fully eluci-
dated. However, we found a role for inhibition of iNOS expres-
sion and NO production, a process known to be mediated by
CD200 binding to CD200R (Banerjee and Dick, 2004; Cameron
et al., 2005; Copland et al., 2007). Expression of iNOS (NOS2)
in macrophages is stimulated by numerous cytokines andmicro-
bial products, which often act in synergistic pairs (MacMicking
et al., 1997). The effect of LPS and IFN-g in inducing iNOS
expression and NO-mediated killing of L. major (Liew et al.,
1990) has been the subject of numerous studies, which have
largely focused on the potent microbicidal effect associated
with the establishment of a Th1 helper lymphocyte response
(Reiner and Locksley, 1995). However, more recent studies re-
vealed that the role of iNOS expression in L. major infections is
not restricted to the adaptive phase of the immune response.
iNOS-mediated antimicrobial activity dependent on type 1 inter-
ferons (IFN-a, IFN-b) was detected within the first day after para-
site inoculation into mice and identified as part of the innate
immune response to Leishmania (Bogdan et al., 2000; Buxbaum,
2010; Diefenbach et al., 1998). IFN-a was also shown to syner-
gize with subactivating doses of LPS, activating macrophages
to produce NO and kill intracellular L. major (Shankar et al.,
1996). The fact that we detected iNOS expression and NO
production by macrophages after short periods of infection
(1–6 hr) adds significant additional information to the poorly
understood innate response to Leishmania and indicates thatCell Host & Microbe 9, 463–4parasite components may be sufficient
to provide the molecular signals required
for this early response. Despite the
detectable levels of iNOS present in iso-
lated WT macrophages infected with
L. amazonensis, NO production by these
cells could only be measured 18–24 hr
after infection. In contrast, in infected
macrophages lacking CD200, iNOS
levels were elevated and resulted in
detectable NO production as early as6 hr after infection. It is important to note that the NO levels we
observed in these assays, using a sensitive fluorescence-based
assay, are markedly lower than the levels observed after lipo-
polysaccharide (LPS) and IFN-g stimulation of macrophages
(see Figure S2). This observation is consistent with our finding
that CD200 deficiency in macrophages impairs parasite replica-
tion over a period of 48 hr, rather than parasite killing, which is
observed in IFN-g-activated macrophages and appears to
require higher NO levels (Liew et al., 1990).
Our in vivo experiments show that the progressive cutaneous
lesions typical of L. amazonensis infections shift to a healing
pattern in CD200-deficient mice and that L. major-induced
lesions can be transformed into a nonhealing pattern by
CD200 inoculation. Taken together with our observations in iso-
lated macrophages, these results suggest that the CD200-medi-
ated suppression of iNOS expression seen shortly after cell entry
may also play a role in the stimulation of lesion progression in-
vivo. However, important aspects of the long-term in vivo
immune responses that develop in the presence or absence of
CD200 remain to be determined, such as whether CD200
expression affects the normal Th1 subset development that
occurs in mice infected with L. major (Reiner and Locksley,
1995). It will also be of interest to determine if parasite-induced
expression of CD200 plays a role in the functional impairment
of dendritic cells infected with L. amazonensis (Boggiatto et al.,
2009; Xin et al., 2008).
The increased susceptibility of Balb/c mice to L. major
infection, with extensive parasite proliferation at sites of inocula-
tion in vivo, is well documented (Nasseri and Modabber, 1979;
Belosevic et al., 1989; Reiner and Locksley, 1995). In resistant
mice from the C57BL/6 background, the L. major tissue load71, June 16, 2011 ª2011 Elsevier Inc. 467
Figure 5. CD200 Transforms the Mild
L. major Infection into a Virulent Pattern
Typical of L. amazonensis
(A) Intracellular parasites in WT or CD200/
BMMs infected for 1 hr with L. amazonensis lesion-
derived amastigotes and either fixed immediately
or after incubation for 24 or 48 hr. Results corre-
spond to mean ± SD of triplicates. *p < 0.0379;
**p < 0.0018.
(B) Intracellular parasites in WT or CD200/
BMMs infected for 1 hr with L. major lesion-
derived amastigotes, in the presence or not of
CD200-Fc. Results correspond to mean ± SD of
triplicates. **p < 0.0011; *p < 0.0142 (Student’s t
test).
(C) Lesion size during L. amazonensis (green) or
L. major (red) infection in WT mice, treated with
CD200-Fc (open circles) or control IgG1-Fc
(closed circles). Results correspond to mean ± SD
(n = 5). L. amazonensis: **p = 0.038; *p = 0.077;
L. major: *p = 0.039, **p = 0.005 (6th week), p =
0.0054 (7th week), ***p = 0.0002 (8th week), p =
0.0001 (9th week) (Student’s t test).
(D) Parasite load in footpads from the experiment
in (C), 9 weeks following infection with
L. amazonensis (green) or L. major (red). Results
correspond to mean ± SD (n = 5). L. amazonensis
*p = 0.025; L. major ***p = 0.0004 (Student’s t test).
Cell Host & Microbe
Leishmania Virulence Requires CD200 Expressionincreases slowly in the first fewweeks after infection, followed by
a decline that coincides with lesion healing (Sacks and Noben-
Trauth, 2002). However, very few studies have addressed in
detail the rate of L. major replication in isolated macrophages
from susceptible and resistant mouse strains. Most reports
show increases in intracellular parasite numbers only after long
periods of infection, such as 72 hr (Blos et al., 2003) or longer.
The numbers of intracellular L. major were reported to remain
constant in the first 48 hr of infection in Balb/c BMMs (Muleme
et al., 2009), and studies performed with C57BL/6 or CH3/
HeNHSD BMMs showed either a very small increase (Green
et al., 1990; Mattner et al., 2000) or a reduction in parasite
numbers during this period (Kuang et al., 2009). These observa-
tions are consistent with our present study, where we show that
only L. amazonensis is able to double its numbers intracellularly
every 24 hr, while the number of intracellular L. major stays
constant during this period. Our results suggest that CD200-
mediated suppression of Leishmania intracellular growth may
also influence lesion progression in vivo, although additional
factors must also come into play as the acquired immune
response develops in infected animals.468 Cell Host & Microbe 9, 463–471, June 16, 2011 ª2011 Elsevier Inc.Consistent with the increased suscep-
tibility of CD200/ animals to autoim-
mune and inflammatory diseases
(Hoek et al., 2000), deficiency in CD200
or CD200R leads to exacerbated res-
ponses to infections with microbes
such as influenza (Snelgrove et al.,
2008) and Neisseria meningitidis (Mukho-
padhyay et al., 2010). In those studies,
the observed pathology was mediated
by an uncurtailed systemic responseagainst the pathogen, rather than an intrinsic increase in
pathogen virulence. In sharp contrast with these observations,
we found that CD200-deficient mice are more resistant to
infection with virulent L. amazonensis, without any obvious
evidence of additional pathology. The anti-inflammatory
environment generated during Leishmania infections (Sacks
and Noben-Trauth, 2002) may play a role in this process, by
masking the damaging consequences of systemic CD200
deficiency.
CD200 is thought to control the activation of CD200R-ex-
pressing myeloid cells by establishing trans-cellular interactions
(Barclay et al., 2002; Hatherley and Barclay, 2004). Thus, we
envision that CD200 molecules expressed in response to
L. amazonensis infection interact with CD200R on neighboring
macrophages, dampening the overall ability of the host cell pop-
ulation to control intracellular parasite growth through suppres-
sion of the microbicide NO. Our experiments demonstrate that
signaling mediated by CD200 can suppress NO production
and promote Leishmania growth within a homogeneous popula-
tion of culturedmacrophages. In vivo, it is conceivable that addi-
tional cell types may also respond to L. amazonensis infection by
Cell Host & Microbe
Leishmania Virulence Requires CD200 Expressionexpressing CD200, expanding the parasites’ ability to evade
host microbicidal activity.
EXPERIMENTAL PROCEDURES
Leishmania Culture and Purification
L. amazonensis (IFLA/BR/67/PH8) and L. major (clone VI, MHOM/IL/80/Fried-
lin) were propagated as promastigotes at 26C in M199 media supplemented
with 5%penicillin/streptomycin, 0.1%hemin (25mg/ml in 0.1 NNaOH), 10mM
adenine, and 10% FBS (pH 7.5). Metacyclic forms of L. amazonensis and
L. major were purified by agglutination of stationary-phase promastigote
cultures using the 3A.1 mAb (Pinto-da-Silva et al., 2005) and peanut agglutinin
(Sigma) (Sacks and Melby, 2001), respectively. To generate L. amazonensis
axenic amastigotes, cultures rich in metacyclic forms were incubated in
M199 media supplemented with 0.25% glucose, 0.5% trypticase, 40 mM
sodium succinate (pH 4.5), 20% FBS, and 5% penicillin/streptomycin at 2 3
106/ml at 32C for a minimum of 6 days and then cultured axenically at
32C. Parasites were washed three times in PBS before use in experiments.
To obtain lesion amastigotes, female Balb/c mice were infected with purified
metacyclic promastigotes of L. amazonensis or L. major. After 4–5 weeks,
the animals were euthanized and the parasites recovered from footpad
lesions, as described (Sacks and Melby, 2001). The lesion homogenate rich
in amastigotes was submitted to sequential 20003 g centrifugation steps to
separate parasites from tissue debris.
Mouse Infections and Quantification of Parasite Load
Female WT C57BL/6 mice (obtained from Jackson Laboratory) and CD200/
mice generated in the C57BL/6 background (Hoek et al., 2000) (obtained from
Schering-Plough BioPharma) were bred and used under protocols approved
by the Institutional Animal Care and Use Committee at the Yale University
School of Medicine. Female WT or CD200/ 8-week-old C57BL/6 mice
were injected in the left hind footpad with 106 purified metacyclic promasti-
gotes of L. amazonensis or L. major, and lesion progression was followed
by blinded weekly measurements with a caliper. Inoculations of CD200-Fc
or IgG1-Fc were done as described (Snelgrove et al., 2008), with some modi-
fications. Mice were injected intraperitoneally with 10 mg of recombinant
CD200-Fc chimera (3355-CD, R&D Systems) or control human IgG1-Fc
(110-HG, R&D Systems) in PBS on days 1, 3, and 6 after infection, followed
by weekly injections throughout the experiment. The total number of parasites
in the injected footpad was estimated by a limiting dilution assay as previously
described (Sacks and Melby, 2001; Titus et al., 1985), with minor modifica-
tions. Footpad tissues were ground in a Medimachine (Becton Dickinson)
and mechanically dissociated using a pellet pestle in 100 ml of Dulbecco’s
modified Eagle’s medium containing 100 U/ml penicillin and 100 mg/ml strep-
tomycin. Tissue homogenates were filtered in a 70 mm pore-size cell strainer
(Falcon Products, Inc.) and serially diluted in a 96-well flat-bottom microtiter
plate containing biphasic medium prepared using 30 ml of NNN medium con-
taining 20% defibrinated rabbit blood and overlaid with 100 ml of M199
medium. The number of viable parasites was calculated from the highest dilu-
tion at which promastigote growth could be observed after 10 days of incuba-
tion at 26C.
Affymetrix Gene Chip Analysis
C57BL/6 BMMs plated at 2.53 105 in 10 cm dishes were either not infected or
infected with L. amazonensis amastigotes at moi = 10 for 30 min at 34C. After
infection, cells were washed three times in PBS and further incubated for the
appropriate periods. Total RNA was isolated using TRIzol (Invitrogen) and
analyzed using an Affymetrix Gene Chip protocol, as previously described
(Wilson et al., 2008). The Affymetrix protocol, used to analyze RNA extracted
from BMMs infected for 48 hr with L. amazonensis amastigotes, was essen-
tially as described (GeneChip Expression Analysis Technical Manual, Affyme-
trix). cRNA was hybridized for 16 hr to Affymetrix GeneChip Mouse Genome
430 2.0 Array, which contain 45,000 probe sets for the analysis of 39,000 tran-
scripts and variants from over 34,000 mouse genes. Normalization was
performed using G-C-corrected robust multiarray average (GC-RMA). Identifi-
cation of significantly perturbed genes was done using significance analysis of
microarrays. The false positive rate was 0.1%.Cell HQuantitative Real-Time PCR
Real-time PCR was performed using a BioRad iQ icycler Detection system
(BioRad Laboratories) using SYBR green fluorophore (BioRad Laboratories)
according to the manufacturer’s instructions. Oligonucleotide primers
50-GAA TCA AAC AAT ACA GAA TG- 30 and 50-TGC CCC CCA CCA GTA
ACA TGG- 30 were used to amplify a portion of the CD200 cDNA or 50-TCA
GTC AAC GGG GGA CAT AAA-30 and 50-GGG GCT GTA CTG CTT AAC
CAG-30 to amplify the control cDNA HPRT1. The reaction was incubated for
3 min at 95C and then for 45 cycles of 20 s at 95C followed by 30 s at
55C. Fluorescence was detected at each annealing step, and the cycle
threshold (Ct) was calculated by determining the point at which the fluores-
cence exceeded a threshold limit. All reactions were performed in triplicate,
and negative controls (no template cDNA) were included in each experiment.
The data were normalized by the level of HPRT1 expression in individual
samples.Quantification of Leishmania Intracellular Growth in Macrophages
Mouse BMMs were prepared as previously described (Becker et al., 2009).
A total of 1 3 105 BMMs were plated on glass coverslips in 3 cm dishes
24 hr prior to experiments. Purified recombinant CD200-Fc (3355-CD, R&D
Systems) or the control construct IgG1-Fc (110-HG, R&D Systems) was added
at 2 mg/ml. The nitric oxide synthase inhibitors N-methyl-L-arginine (L-NMMA,
active form) or N-methyl-D-arginine (D-NMMA, inactive form) were added at
500 mM (Sigma) (Iniesta et al., 2001; Koblish et al., 1998) for 30 min, followed
by a PBS wash prior to infection. Axenic or lesion amastigotes were then
added at a moi = 2 in RPMI 10% FBS for 1 hr at 34C. After invasion, cells
were washed three times in PBS and incubated for the indicated times at
34C. Coverslips were then fixed in 4% paraformaldehyde (PFA), and host
cell and parasite DNA were stained with 10 mg/ml DAPI for 1 hr, after perme-
abilization with 0.1% Triton X-100 for 10 min. The number of intracellular para-
sites was quantified by scoring the total number of macrophages and the total
number of intracellular parasites (clearly identifiable by visualization of the par-
asitophorous vacuole by phase microscopy) per microscopic field (1003 N.A.
1.3 oil immersion objective, Nikon E200 epifluorescence microscope). The
results were expressed as intracellular parasites per 100 macrophages. At
least 300 host cells, in triplicate, were analyzed for each time point. For immu-
nofluorescence, PFA-fixed cells were washed with PBS, quenched with
15 mM NH4Cl for 15 min, and permeabilized with saponin/PBS (0.1%) prior
to staining with rat anti-mouse Lamp1 mAb (Developmental Studies
HybridomaBank) for 1 hr, followed by 1 hr incubation with anti-rabbit IgGAlexa
Fluor 488. For parasite staining, coverslips were permeabilized with 0.1%
Triton X-100 for 3 min and incubated with mouse polyclonal antibodies
prepared against axenic amastigotes of L. amazonensis, followed by anti-
mouse IgG Texas red. All samples were incubated with 10 mg/ml DAPI for
nuclei staining. Secondary antibodies were purchased fromMolecular Probes.
Images were either acquired through a 1003 objective using a Zeiss Axiovert
microscope equipped with a Hamamatsu Orca II cooled CCD camera
controlled by Metamorph Software (Molecular Devices) or with a Leica SPX5
confocal microscope using a 633/1.4 objective.Western Blot and Immunoprecipitation
A total of 15 mg of protein/well was separated under reducing conditions on
a 10% SDS polyacrylamide gel, blotted onto nitrocellulose membranes using
a Trans-blot Transfer system (Bio-Rad Laboratories) overnight at 40V, and
probed with rabbit anti-mouse iNOS (Abcam) and mouse anti-mouse actin
(Sigma) followed by peroxidase-conjugated secondary antibodies. CD200
protein detection was performed using the Pierce Crosslink Immunoprecipita-
tion Kit as described by the manufacturer (Thermo Scientific). Briefly, samples
were added to columns containing goat anti-mouse CD200 antibodies (R&D
Systems) crosslinked to protein G/A beads. After several washes, elution
buffer (20 ml) was added, and the eluate samples were separated under
reducing conditions on a 10% SDS polyacrylamide gel, blotted onto nitrocel-
lulose membranes, and probed with goat anti-CD200 antibodies followed by
peroxidase-conjugated secondary antibodies. Immunoblots were developed
using Supersignal West Pico Chemiluminescent Substrate (Thermo Scientific)
and detected using a Fuji LAS-3000 Imaging System and Image Reader
LAS-3000 software.ost & Microbe 9, 463–471, June 16, 2011 ª2011 Elsevier Inc. 469
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Nitrite concentrations in BMMculture supernatants were used as ameasure of
NO production and quantified using a Fluorometric Assay Kit (Biovision) or
modified Griess reagent (Sigma), as described by the manufacturers. Before
quantification, all samples were centrifuged at 8003 g to remove cellular
debris and filtered in Amicon Ultra device filters (Millipore). Absorbance was
measured at 450 nm after excitation at 360 nm for the Fluorometric Assay
Kit and at 540 nm for the modified Griess reagent. The concentration of NO
(total nitrite concentration) in each sample was calculated from standard curve
determinations as provided by the manufacturers.
Statistical Analysis
Statistical significance between means of various groups was determined
using an unpaired Student’s t test for independent samples (GraphPad Prism
software). Values of 0.05 or less were considered significant.
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